Publications by authors named "D Vilar-Compte"
Article Synopsis
- Patients with cancer have a higher risk of developing infective endocarditis (IE), which can lead to worse health outcomes.
- A retrospective study conducted in Mexico City from 2006 to 2022 matched 36 cancer patients with 72 controls without cancer to identify factors related to IE.
- Key risk factors for IE in cancer patients included obesity, recent surgery, and invasive procedures, with S. aureus infections linked to a higher incidence of systemic embolization, although mortality rates were similar between both groups.
Objectives: Vaccination is the best preventive measure for SARS-CoV-2 infection; however, efficacy is lower in cancer patients. During the pandemic period, Mexico was characterized by the use of seven different COVID-19 vaccine platforms, and oncologic patients were not prioritized for vaccination. We report the outcomes of COVID-19 in cancer patients after the beginning of the national vaccine campaign in Mexico.
View Article and Find Full Text PDFMulticenter study on infections in Mexico: exploring the landscape.
Infect Control Hosp Epidemiol
October 2024
Article Synopsis
- - The study examined Clostridioides difficile infection (CDI) trends and outcomes in 16 healthcare facilities in Mexico from 2016 to 2022, focusing on patient demographics and clinical data.
- - Out of 2,356 CDI cases identified, 90% were healthcare-associated, with common comorbidities including hypertension and diabetes; the 30-day mortality rate was 16%.
- - The findings highlight the need for improved surveillance and standardized CDI classification in Mexico, noting stable rates but differences in incidence between public and private hospitals.
Introduction:: Patients with thoracic cancers have one of the highest mortality rates among patients with cancer and COVID-19. Data evaluating the impact of recent anti-cancer therapies on COVID-19 outcomes in patients with thoracic cancers are confined to heterogenous studies with limited follow-up data. We leveraged data from the COVID-19 and Cancer Consortium (CCC19) (NCT04354701) to analyze the impact of recent anti-cancer therapies on the clinical outcomes of COVID-19 in patients with thoracic cancers.
View Article and Find Full Text PDFPseudomonas fluorescens CRBSI outbreak: complying with the standardization of invasive procedures is a step ahead in the fight against antimicrobial resistance.
Antimicrob Resist Infect Control
April 2024
In the healthcare sector, the implementation of standardized procedures, such as those commonly employed in franchises to ensure consistent quality, remains underprioritized. Within this framework, we focus on the importance of standardized central venous catheter (CVC) insertion procedures to prevent healthcare-associated outbreaks. While antimicrobial resistance (AMR) may still not be the most prevalent problem in some institutions, its increasing significance certainly underlines the urgency of infection prevention.
View Article and Find Full Text PDF